DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Atacand (Candesartan Cilexetil) - Current Clinical Trials

 
 



Atacand Related Clinical Trials

Atacand Dose Ranging in Hypertensive Pediatric Subjects 1 Year to Less Than 6 Years of Age [Active, not recruiting]

Compliance of Patients With Essential Hypertension Treated With Candesartan or Candesartan/Hydrochlorothiazide [Completed]

Candesartan and Candesartan/ Hydrochlorothiazide in the Treatment of Patients With Hypertension and LVH [Completed]

DIabetic Retinopathy Candesartan Trials. [Active, not recruiting]

Antihypertensive Efficacy and Safety of Candesartan/HCT 32/12.5 and 32/25 mg in Comparison With Candesartan 32 mg [Completed]

Candesartan Cilexetil in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Added) [Completed]

Candesartan Cilexetil in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Preserved) [Completed]

Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Alternative) [Completed]

The Potential of Candesartan to Retard the Progression of Aortic Stenosis [Recruiting]

Diabetic Retinopathy Candesartan Trials [Active, not recruiting]

DIabetic Retinopathy Candesartan Trials [Active, not recruiting]

TROPHY - Candesartan Cilexetil Long-Term Hypertension Prevention Trial [Completed]

Candesartan Effectiveness Study in Pro-BNP [Active, not recruiting]

A Pharmacogenomic Study of Candesartan in Heart Failure [Recruiting]

High Doses of Candesartan Cilexetil on the Reduction of Proteinuria [Completed]

Antihypertensive Efficacy and Safety of Candesartan/HCT 32/25 mg in Comparison With Individual Components and Placebo [Completed]

Study to Characterize the Long-Term Clinical Experience of Atacand in Hypertensive Children Ages 1 to<11 Years [Enrolling by invitation]

Evaluating the Effect of Candesartan vs Placebo in Prevention of Trastuzumab-associated Cardiotoxicity [Recruiting]

An ACE Inhibitor (Perindopril) or an Angiotensin Receptor Blocker (Candesartan) as a Treatment for Methamphetamine Dependence [Recruiting]

The Clinical Study to Evaluate the Efficacy and Safety of Fimasartan in Patients With Mild to Moderate Essential Hypertension [Recruiting]

Evaluation of Clinical Signs and Symptoms of Chronic Heart Failure in Patients Treated With Candesartan Cilexetil in Croatia [Recruiting]

ARIA(Atacand Renoprotection In NephropAthy Pt.) [Recruiting]

Candesartan Effect in Second Stage Arterial Hypertension [Recruiting]

Candesartan for Prevention of Cardiovascular Events After Cypher or Taxus Coronary Stenting (4C) Trial [Recruiting]

COmpliance and Efficacy in Mono and Combination Tablet Study ATacand/Atacand Plus [Recruiting]

Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial of Cardiovascular Events in High-Risk Hypertensive Patients [Active, not recruiting]

Atacand (Candesartan) Real Life Study [Recruiting]

A Randomized, Double-Blind, Active Control Trial Comparing Effects of Telmisartan, Candesartan and Amlodipine, Alone or Plus Metformin, on Non-Diabetic, Obese Hypertensive Patients [Recruiting]

Double-Blind Randomized Cross-Over Trial Comparing Metabolic Effects of Candesartan, Hydrochlorothiazide and Placebo [Completed]

Clinical Trial to Assess the Effects of Candesartan on the Carbohydrate Metabolism of Obese Subjects [Recruiting]

Observational Usage and Efficacy Study of Candesartan in Heart Failure Treatment in France [Recruiting]

Efficacy and Safety of a Therapy Change From Candesartan 32 mg to Fixed Combination of Olmesartan 40 mg/Amlodipine 10 mg [Recruiting]

Cognitive Function and Electrocardiogram (ECG) During Hypoglycemia and Blockade of the Renin-angiotensin System [Recruiting]

Candesartan Versus Propranolol for Migraine Prevention [Recruiting]

CCB Safety Study in Treatment of Hypertension of ADPKD [Not yet recruiting]

Effects of Angiotensin Converting Enzyme (ACE) Inhibitors Versus Candesartan in Reducing Cardiovascular Events in Primary Treatment of Hypertension [Not yet recruiting]

Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension [Recruiting]

Effects of Antihypertensive Treatment in HIV Infected Patients: Candesartan Versus Lercanidipine [Recruiting]

Acute Candesartan Cilexetil Outcomes Stroke Trial (ACCOST) [Active, not recruiting]

Angiotensin-II Blockade in Mitral Regurgitation [Completed]

Imidapril and Candesartan on Fibrinolysis and Insulin-Sensitivity in Patients With Mild to Moderate Hypertension [Recruiting]

Pharmacodynamic Influences of Candesartan, Atenolol, Hydrochlorothiazide and Drug Combinations in Hypertensive Patients. [Recruiting]

Pulse Wave Velocity, Pulse Wave Morphology and Blocking of the Reninangiotensin System in Patients With Chronic Kidney Disease [Recruiting]

Efficacy of Candesartan on Symptomatic Heart Failure in Treating Diabetic and Hypertensive Patients. [Recruiting]

Efficacy, Safety, & Pharmacokinetics of Candesartan Cilexetil in Hypertensive Paediatric Subjects 6 to < 17 Years of Age [Completed]

The Study to Evaluate Efficacy and Safety of Candesartan vs Losartan in Hypertension With Heart Failure (HONOR) [Recruiting]

Effectiveness of Candesartan and Telmisartan on Morning Hypertension in Japanese Obese Patients [Recruiting]

Atacand Dose Range Finding Study in Pediatric Subjects 6 to <17 Years of Age [Completed]

In-Practice Evaluation of Atacand 16mg Antihypertensive Effect [Recruiting]

Study to Demonstrate the Non-Inferiority of Olmesartan Medoxomil Versus Candesartan Cilexetil in Reducing Blood B-Type (or Brain) Natriuretic Peptide Levels at Week 24 [Recruiting]

Effects of Telmisartan on Ischemic Cardiovascular Events in High-risk Hypertensive Patients [Recruiting]

Investigation of Vascular Relaxing Effects of Candesartan and Pioglitazone. [Completed]

Scandinavian Candesartan Acute Stroke Trial (SCAST) [Recruiting]

Efficacy Observational Study of Candesartan Cilexetil on Hypertensive Patients [Recruiting]

Heart Outcomes Prevention Evaluation-3 [Recruiting]

Prophylactic Treatment of Episodic Cluster Headache [Recruiting]

Serial BNP Measurements and Time to Disappearance of S3 in Goal-Directed Therapy of ADHF [Not yet recruiting]

Candesartan in the Prevention of Relapsing Atrial Fibrillation [Completed]

Safety and Tolerability of MK5478 in Patients With Hypertension (5478-001) [Recruiting]

Angiotensin Receptor Blockade as an Anti-Fibrotic Intervention in Patients With Chronic Hepatitis C [Not yet recruiting]

Define in Humans With Compensated CHF and Renal Dysfunction, the Modulating Action of Chronic AT1 Receptor Blockade in Addition to ACE Inhibition on Cardiorenal and Humoral Function [Recruiting]

Diabetes Type 1, Treatment Study Atacand/Placebo After Kidney Biopsy [Active, not recruiting]

Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Fixed Dose Combination in Hypertensive Patients Not Controlled by the Free Combination of an Angiotensin Receptor Blocker Plus Hydrochlorothiazide [Completed]

Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy [Recruiting]

CHANCE - Candesartan in Hypertrophic Cardiomyopathy [Active, not recruiting]

Safety and Effects of Ramipril Combined With Candesartan [Completed]

Sevicontrol-1: Efficacy and Safety of a Fixed Combination of Olmesartan/ Amlodipine [Recruiting]

Angiotensin II Antagonism of TGF-Beta 1 [Completed]

Comparison of Vascular Remodeling Between Different Antianginal Medication Evaluated by Noninvasive ECG-gated Fundus Photographic Evaluation [Not yet recruiting]

High Dose Candesartan Versus Quinapril for Restenosis Prophylaxis After Stent Angioplasty [Completed]

Changes After Angiotensin Converting Enzyme (ACE) Inhibitor Replacement by Angiotensin II Receptor Type I (AT1) Blocker [Recruiting]

The RAS, Fibrinolysis and Cardiopulmonary Bypass [Recruiting]

Goal-directed Afterload Reduction in Acute Congestive Cardiac Decompensation Study [Recruiting]

The Antihypertensives and Vascular, Endothelial and Cognitive Function Trial [Recruiting]

Non-Insulin Dependent Diabetes Mellitus (NIDDM) and Angiotensin Converting Enzyme 2 (ACE2): Diabetic Patients Treated With Antihypertensive Drugs [Not yet recruiting]

Benefits of Medical Therapy Plus Stenting for Renal Atherosclerotic Lesions [Recruiting]

Danish Hypertension Prevention Project - DHYPP [Active, not recruiting]

Study of Optimal Treatment Plan in Hypertensives With Anti-AT1-Receptor Autoantibody [Recruiting]

The Renin-Angiotensin System in Essential Hypertension [Recruiting]

Prognostic Value of the Circadian Pattern of Ambulatory Blood Pressure for Cardiovascular Risk Assessment [Recruiting]

Angiotensin-II Blockade in Mitral Regurgitation

Effect of Angiotensin II Receptor Blockers (ARB) on Left Ventricular Reverse Remodelling After Aortic Valve Replacement in Severe Valvular Aortic Stenosis [Recruiting]

Evaluation of Heart Failure Treatment Guided by NTproBNP vs Clinical Symptoms and Signs Alone [Recruiting]

Effects of Sodium Intake on(PK)/PD) Relationship of a Single Dose of a Renin Angiotensin System-Blocker [Recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012